Previous 10 | Next 10 |
Perrigo Company ( PRGO ) Q2 results : Revenues: $1,149M (-3.2%). More news on: Perrigo Company plc, Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...
Perrigo (NYSE: PRGO ): Q2 Non-GAAP EPS of $0.86 beats by $0.06 ; GAAP EPS of $0.07 misses by $0.15 . More news on: Perrigo Company plc, Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...
DUBLIN , Aug. 8, 2019 /PRNewswire/ -- GAAP ("reported") net sales were $1.15 billion , reflecting a 3% decline versus the prior year period. Non-GAAP ("adjusted") net sales increased by approximately 1% excluding the unfavorable impact of currency and exited businesses. Second qu...
ACIW , AMC , AMRC , AZUL , BAM , BPMP , CAH , CBB , CCOI , CEVA , CNNE , COMM , COT , CRON , CSWI , EBIX , ECOM , EGRX , EPAM , ESPR , FOCS , FOLD , GOGO , GTT , HIMX , HMHC , IBP , KDP , KHC , KOP , KTB , LAUR , LITE , LKSD , LNG , MGA , MMS , MPAA , ...
DUBLIN , Aug. 7, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading provider of "Quality Affordable Self-Care Products ™ " , today announced that Jeffrey C. Smith , Managing Member, Chief Executive Officer, and Chief Investment Officer of Starboard Value LP, w...
Drug distributors McKesson ( MCK -4.9% ), Cardinal Health ( CAH -5.4% ) and AmerisourceBergen ( ABC -4.7% ) are under pressure in apparent response to a Bloomberg repor t that they have proposed paying a total of $10B to settle all claims related their respective roles in the opioid e...
Two small-cap stocks on the radar today include SailPoint Technologies (NYSE:SAIL) and PetIQ (NASDAQ:PETQ). Let’s check out the potential here. Small-Cap Stocks to Watch: SailPoint At a current price of $20.93 USD, SailPoint Technologies could be an undervalued play. Af...
Background Pfizer ( PFE ) is spinning off its Upjohn unit and combining it with generic drugmaker Mylan ( MYL ) to create a giant off-patent group with global annual revenues worth about $20 billion. The all-stock deal will unite former branded blockbusters like Lipitor and Viagra with Myl...
The WSJ reports that Pfizer (NYSE: PFE ) is in talks with Mylan N.V. (NASDAQ: MYL ) to combine its off-patent drugs business with the latter. More news on: Pfizer Inc., Mylan N.V., Teva Pharmaceutical Industries Limited, Healthcare stocks news, Merger & acquisition news, Stocks on th...
DUBLIN , July 25, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), today announced that it will release its second quarter calendar year 2019 financial results on Thursday, August 8, 2019 . The Company will host a conference call beginning at 8 a.m. (EDT) . The conf...
News, Short Squeeze, Breakout and More Instantly...
Perrigo to Release Second Quarter 2024 Financial Results on August 2, 2024 PR Newswire DUBLIN , July 19, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its secon...
2024-07-19 06:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Perrigo Completes Divestment of HRA Pharma Rare Diseases Business PR Newswire DUBLIN , July 10, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE PRGO) ("Perrigo" or the "Company"), a leading provider of Consumer Self-Care Products, today announced that it has compl...